Celldex Therapeutics, Inc. — Director's Dealing 2009

Nov 9, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2009-11-09

Reporting Person: Marucci Anthony S (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-11-09	Common Stock	P	200	$5.079	Acquired	200	Direct
2009-11-09	Common Stock	P	1000	$5.084	Acquired	1000	Direct
2009-11-09	Common Stock	P	800	$5.086	Acquired	800	Direct
2009-11-09	Common Stock	P	300	$5.089	Acquired	300	Direct
2009-11-09	Common Stock	P	1200	$5.096	Acquired	1200	Direct
2009-11-09	Common Stock	P	400	$5.108	Acquired	400	Direct
2009-11-09	Common Stock	P	1100	$5.109	Acquired	1100	Direct
2009-11-09	Common Stock	P	5000	$5.10	Acquired	5000	Direct